<VariationArchive VariationID="2691462" VariationName="NM_018122.5(DARS2):c.161dup (p.Cys54fs)" VariationType="Duplication" Accession="VCV002691462" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2024-02-04" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2852486" VariationID="2691462">
      <GeneList>
        <Gene Symbol="DARS2" FullName="aspartyl-tRNA synthetase 2, mitochondrial" GeneID="55157" HGNC_ID="HGNC:25538" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="173824673" stop="173858546" display_start="173824673" display_stop="173858546" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="173793796" stop="173827681" display_start="173793796" display_stop="173827681" Strand="+" />
          </Location>
          <OMIM>610956</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018122.5(DARS2):c.161dup (p.Cys54fs)</Name>
      <CanonicalSPDI>NC_000001.11:173826719:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="173826719" stop="173826720" display_start="173826719" display_stop="173826720" variantLength="1" positionVCF="173826719" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="173795857" stop="173795858" display_start="173795857" display_stop="173795858" variantLength="1" positionVCF="173795857" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>C54fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018122.5" sequenceAccession="NM_018122" sequenceVersion="5" change="c.161dupG" MANESelect="true">
            <Expression>NM_018122.5:c.161dupG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.173795858dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.173795858dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.173826720dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.173826720dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016138.1" sequenceAccession="NG_016138" sequenceVersion="1" change="g.7062dup">
            <Expression>NG_016138.1:g.7062dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365212.1" sequenceAccession="NM_001365212" sequenceVersion="1" change="c.161dup">
            <Expression>NM_001365212.1:c.161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352141.1" sequenceAccession="NP_001352141" sequenceVersion="1" change="p.Cys54fs">
            <Expression>NP_001352141.1:p.Cys54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365213.2" sequenceAccession="NM_001365213" sequenceVersion="2" change="c.161dup">
            <Expression>NM_001365213.2:c.161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352142.1" sequenceAccession="NP_001352142" sequenceVersion="1" change="p.Cys54fs">
            <Expression>NP_001352142.1:p.Cys54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018122.5" sequenceAccession="NM_018122" sequenceVersion="5" change="c.161dup" MANESelect="true">
            <Expression>NM_018122.5:c.161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060592.2" sequenceAccession="NP_060592" sequenceVersion="2" change="p.Cys54fs">
            <Expression>NP_060592.2:p.Cys54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1270" sequenceAccession="LRG_1270">
            <Expression>LRG_1270:g.7062dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1270t1" sequenceAccession="LRG_1270t1">
            <Expression>LRG_1270t1:c.161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1270p1" sequenceAccession="LRG_1270p1" change="p.Cys54fs">
            <Expression>LRG_1270p1:p.Cys54fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018122.5(DARS2):c.161dup (p.Cys54fs) AND Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome" Accession="RCV003486509" Version="1">
        <ClassifiedConditionList TraitSetID="6292">
          <ClassifiedCondition DB="MedGen" ID="C1970180">Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-04" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6292" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2478" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="610956.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="611105" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation</ElementValue>
                <XRef ID="Leukoencephalopathy+with+Brainstem+and+Spinal+Cord+Involvement+and+Lactate+Elevation/8742" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome</ElementValue>
                <XRef ID="MONDO:0012622" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LBSL</ElementValue>
                <XRef Type="MIM" ID="611105" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12652" />
                <XRef ID="12652" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) is characterized by slowly progressive cerebellar ataxia and spasticity with dorsal column dysfunction (decreased position and vibration sense) in most individuals. The neurologic dysfunction involves the legs more than the arms. The tendon reflexes are retained. Deterioration of motor skills usually starts in childhood or adolescence, but occasionally not until adulthood. Dysarthria develops over time. Occasional findings include epilepsy; learning problems; cognitive decline; and reduced consciousness, neurologic deterioration, and fever following minor head trauma. Individuals with neonatal or early-infantile onset have a severe disease course often associated with early death. Those with childhood onset have slow progression with wheelchair dependence in the teens or twenties. Adult onset is associated with slow progression and mild impairment.</Attribute>
                <XRef ID="NBK43417" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20506600</ID>
                <ID Source="BookShelf">NBK43417</ID>
              </Citation>
              <XRef ID="137898" DB="Orphanet" />
              <XRef ID="C1970180" DB="MedGen" />
              <XRef ID="MONDO:0012622" DB="MONDO" />
              <XRef Type="MIM" ID="611105" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7917740" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_018122.5:c.161dupG|MedGen:C1970180" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004241818" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: DARS2 c.161dupG (p.Cys54TrpfsX45) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 251462 control chromosomes. To our knowledge, no occurrence of c.161dupG in individuals affected with Leukoencephalopathy With Brain Stem And Spinal Cord Involvement-High Lactate Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DARS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018122.5:c.161dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1970180" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14175850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7917740" TraitType="Disease" MappingType="XRef" MappingValue="C1970180" MappingRef="MedGen">
        <MedGen CUI="C1970180" Name="Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

